Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
44.20
-0.56 (-1.25%)
At close: May 12, 2025, 4:00 PM
45.12
+0.92 (2.08%)
After-hours: May 12, 2025, 5:08 PM EDT
Tarsus Pharmaceuticals Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Tarsus Pharmaceuticals stock have an average target of 66.33, with a low estimate of 51 and a high estimate of 84. The average target predicts an increase of 50.07% from the current stock price of 44.20.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Tarsus Pharmaceuticals stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 3 | 3 | 3 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Hold Maintains $46 → $51 | Hold | Maintains | $46 → $51 | +15.38% | May 5, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $78 → $84 | Strong Buy | Maintains | $78 → $84 | +90.05% | May 2, 2025 |
| Jefferies | Jefferies | Strong Buy Maintains $54 → $58 | Strong Buy | Maintains | $54 → $58 | +31.22% | Mar 6, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $75 → $78 | Strong Buy | Maintains | $75 → $78 | +76.47% | Feb 26, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $73 | Strong Buy | Reiterates | $73 | +65.16% | Feb 26, 2025 |
Financial Forecast
Revenue This Year
390.20M
from 182.95M
Increased by 113.28%
Revenue Next Year
597.77M
from 390.20M
Increased by 53.20%
EPS This Year
-1.57
from -3.07
EPS Next Year
1.32
from -1.57
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 452.2M | 747.0M | 890.0M | ||
| Avg | 390.2M | 597.8M | 756.2M | ||
| Low | 344.6M | 499.7M | 657.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 147.2% | 91.4% | 48.9% | ||
| Avg | 113.3% | 53.2% | 26.5% | ||
| Low | 88.3% | 28.1% | 9.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.19 | 2.06 | 6.96 | ||
| Avg | -1.57 | 1.32 | 4.29 | ||
| Low | -1.98 | 0.70 | 2.48 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | 427.6% | ||
| Avg | - | - | 225.5% | ||
| Low | - | - | 88.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.